• Join
  • Login
  • Contact

Search abstracts

Population pharmacokinetics of imatinib mesylate in nigerian patients with chronic myeloid leukemia

  • In: SUBMITTED ORALS on Wednesday, 16 April 2014, 14:30-15:30
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: ADEAGBO, Babatunde (Obafemi Awolowo University, Department of Pharmaceutical Chemistry, Ile-ife, Nigeria)
  • Co-author(s): Bolaji, Oluseye (Obafemi Awolowo University, Ile-ife, Nigeria)
    Olugbade, Tiwalade (Obafemi Awolowo University, Ile-ife, Nigeria)
    Durosinmi, Muheez (Obafemi Awolowo University, Ile-ife, Nigeria)
    Bolarinwa, Rahaman (Obafemi Awolowo University, Ile-ife, Nigeria)
    Ogungbenro, Kayode (University of Manchester, Manchester, United Kingdom)
  • Abstract:

    Background: Population pharmacokinetic studies of imatinib mesylate in Caucasian and Japanese patients with chronic myeloid leukaemia (CML) have shown inter-subject and inter-population clearance variabilities. However, no pharmacokinetic (PK) study has been conducted in an African population since the introduction of the drug.
    Aim: This study..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses